sensitive molecular methods for virus detection, and the results suggest that bacteria might contribute to wheezing episodes in children at high risk. Interventional strategies geared toward these microorganisms might be useful to further our understanding of wheezing and asthma development in these children. Given the paucity of information on evidence-based strategies in young children for treating wheezing episodes, clinical trials for evaluating antimicrobial agents and other interventions for wheezing episodes should be considered and are currently being evaluated among large clinical trial networks. STUDY POPULATION. There were 37 monozygotic twin pairs discordant for RSV hospitalization at a mean age of 10.6 months evaluated in the study. The twins were born between January 1, 1994, and December 31, 2003, and enrolled through the Danish Twin Registry.
METHODS. Hospitalization was used as a marker of disease severity. Participants were studied at a mean age of 7.6 years. The study included clinical examinations, lungfunction testing, fractional exhaled nitric-oxide levels, determination of an asthma diagnosis, use of asthma medication, and results of skin-prick tests to common inhalant allergens.
RESULTS. The prevalence of asthma among the twins was 18%. The twins did not differ with respect to current asthma, use of inhaled corticosteroids or ␤ 2 agonists, atopic dermatitis, fractional exhaled nitric oxide, baseline lung function, bronchial responsiveness, or sensitization (P Ͼ .1 for all comparisons).
CONCLUSIONS. There was no significant difference within cohabiting monozygotic twin pairs discordant for hospitalization for RSV bronchiolitis in infancy on the development of asthma and allergy, which argues against a specific viral effect.
REVIEWER COMMENTS. This study examined the question of which came first: not the chicken or the egg but whether severe RSV bronchiolitis causes wheezing or whether someone with a predisposition to asthma suffers a more severe response to RSV. This study's results argue against a specific effect of severe RSV infection in the development of asthma and allergy. Another recent study report based on 8280 twin pairs showed that a model in which asthma "causes" RSV hospitalization fit significantly better than a model in which RSV hospitalization "causes" asthma. We guess the chicken came first. STUDY POPULATION. The authors studied a subgroup from among a previously described cohort of 293 hospitalized wheezing Finnish children aged 3 months to 16 years who had comprehensive virology performed (N ϭ 247; median age: 1.6 years). Subjects with recent oral corticosteroid use, chronic disease, or ICU treatment were excluded.
METHODS. Respiratory viral infections were evaluated through a nasopharyngeal aspirate and blood sample at baseline and after 2 to 3 weeks. A combination of viral culture, antigen detection, immunoglobulin G (IgG) and IgM measurement, and polymerase chain reaction was used to evaluate for respiratory syncytial virus, human rhinovirus, enteroviruses, human bocavirus, and a broad panel of additional respiratory viruses. Atopy was assessed through serum-specific IgE testing to several common food allergens, cat, dog, horse, birch, mugwort, timothy grass, mold, and dust mite.
RESULTS. Allergen-specific IgE sensitization was closely related to sole rhinovirus infection (odds ratio: 3.5; P ϭ .0002). In contrast, sole respiratory syncytial virus infection was negatively associated with sensitization (odds ratio: 0.087; P ϭ .027). No significant associations with atopy were found with the remaining viruses or with those with multiple concurrent viral infections.
CONCLUSIONS. Acute wheezing in early childhood caused by human rhinovirus is associated with an increased risk of allergic sensitization and, therefore, an increased risk of developing future asthma.
REVIEWER COMMENTS. A limitation of this study lies in the fact that all subjects were hospitalized for their wheezing, thereby representing a minority of children with rhinovirus infection. Nevertheless, when considering the asthma predictive index, the evidence presented from this study suggests that a history of rhinovirus infection, especially severe infection, could be considered an additional risk factor for the development of asthma. Previous work has suggested that obesity is related to asthma through an allergic inflammation pathway. These researchers sought to examine the role of C-reactive protein (CRP) in the association between obesity and asthma among a nationally representative sample of US children and young adults.
STUDY POPULATION. The sample came from the 1999 -2006 National Health and Nutrition Examination Survey (NHANES) and specifically included children aged 2 to 19 who had information on BMI and asthma status (N ϭ 16 074).
METHODS. Atopy was measured by using allergen-specific serum immunoglobulin E; asthma status was measured through self-report of diagnosis by a physician; and BMI was calculated on the basis of height and weight measurements. Multiple logistic regression analysis was used to examine the association between BMI and asthma status.
RESULTS. Nearly 10% of the children reported current asthma. A higher proportion of atopic compared with nonatopic children reported current asthma ( CONCLUSIONS. The association of overweight and obesity with asthma was stronger among nonatopic children. Overweight might lead to systematic inflammation that, in turn, leads to an increased risk of asthma in nonatopic people.
REVIEWER COMMENTS. There is growing evidence that the rise in both obesity and asthma might be related. This study was cross-sectional and limits our understanding of the causal relationship between obesity and asthma. However, it contributes to advancing the evidence in this area by examining the mechanisms through which obesity and asthma might be related-in this case, through nonallergic disease. Future studies can build on these findings by examining these associations prospectively.
PURPOSE OF THE STUDY. To evaluate whether those who were born prematurely were more likely to be prescribed asthma medications in young adulthood than those who were born at term. METHODS. Asthma-medication data were obtained from all outpatient and inpatient pharmacies throughout Sweden. Outcome was defined as prescription of (1) both a ␤ 2 agonist inhalant and a glucocorticoid inhalant or (2) a combination inhalant containing a ␤ 2 agonist and other drugs for obstructive airway diseases.
RESULTS. Young adults who were born extremely prematurely (23-27 weeks' gestation) were 2.4 times more likely to be prescribed asthma medications than those who were born at term (95% confidence interval: 1.41-4.06). No association was found between later prematurity (28 -32 or 33-36 weeks' gestation) and asthma medications in young adulthood.
